These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39333603)

  • 1. Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients.
    Hao S; Gao M; Li Q; Shu L; Wang P; Hao G
    Sci Rep; 2024 Sep; 14(1):22323. PubMed ID: 39333603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
    Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
    Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
    Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
    Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
    Han Z; Jia J; Lv Y; Wang R; Cao K
    Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
    Huang R; Kong Y; Luo Z; Li Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.
    Zhu L; Yuan F; Wang X; Zhu R; Guo W
    Cancer Biomark; 2024; 40(2):185-198. PubMed ID: 38578883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
    Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y
    J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
    Reon BJ; Anaya J; Zhang Y; Mandell J; Purow B; Abounader R; Dutta A
    PLoS Med; 2016 Dec; 13(12):e1002192. PubMed ID: 27923049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma.
    Zhong WJ; Zhang LZ; Yue F; Yuan L; Zhang Q; Li X; Lin L
    Cancer Biomark; 2024; 40(3-4):297-317. PubMed ID: 39213054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
    Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
    J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
    Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
    J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
    Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M
    Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.